[1] Czaja AJ. Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci, 2011, 56(12):3421-3438. [2] Gonzales-Gustavson E, Timoneda N, Fernandez-Cassi X, et al. Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology. PLoS One, 2017, 12(10):e0185911. [3] Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology, 2020, 72(2):671-722. [4] EASL. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol, 2017, 67(1):145-172. [5] Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut, 2019, 68(8):1356-1378. [6] Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology, 2009, 49(3):1017-1044. [7] 刘丽红, 杨永峰, 熊清芳, 等. 470例行肝穿刺活组织检查的不明原因肝病的病因分析. 中华肝脏病杂志, 2019, 27(11):885-889. [8] Berg E, Douwes RM, Meijer V, et al. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity. Dig Liver Dis, 2018, 50(1):68-75. [9] Stefan N, Hring HU, Cusi K. Non alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol, 2019, 7(4):313-324. [10] EASL, EASD, EASO. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol, 2016, 64(6):1388-1402. [11] 中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会, 中华医学会肝病学分会脂肪肝与酒精性肝病学组, 等. 脂肪性肝病诊疗规范化的专家建议(2019年修订版). 实用肝脏病杂志, 2019, 22(6):787-792. [12] Lee WM, Senior JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol, 2005, 33(1):155-164. [13] Wang QX, Yan L, Ma X. Autoimmune hepatitis in the Asia-Pacific area.J Clin Transl Hepatol, 2018, 6(1):48-56. [14] 成军, 李莉. Gilbert综合征的分子遗传学基础. 中华肝脏病杂志, 2002, 10(5):395. [15] 向理科, 罗子国, 李圆圆. Dubin-Johnson等综合征的病理学特征. 中华肝脏病杂志, 2001, 1:45. [16] Arnon R, Rosenberg HK, Suchy FJ. Fibrocystic diseases of the liver, clinical gastroenterology. 2010 edition. Springer: Humana Press, 2010:332-342. [17] 李娟, 刘立伟, 罗娟, 等. Caroli病或Caroli综合征患者21例临床病理特征分析.中华医学杂志,2020,100(38):3005-3009. [18] Stone WL, Basit H, Adil A. Glycogen storage disease. 2021 ed. Treasure Island (FL): StatPearls Publishing, 2021. [19] Khoury J, Zohar Y, Shehadeh N, et al. Glycogenic hepatopathy. Hepatobiliary Pancreat Dis Int, 2018, 17(2):113-118. [20] Hernández-Gea V, Baiges A, Turon F, et al. Idiopathic portal hypertension. Hepatology, 2018, 68(6):2413-2423. |